Moderna Agrees to a Monumental $2.25 Billion Settlement in Patent Lawsuit Over Its COVID-19 Vaccine
In a landmark decision shaking the biotechnology sector, Moderna has agreed to pay up to $2.25 billion to settle a patent infringement lawsuit regarding the pioneering technology used in its COVID-19 vaccine. This settlement resolves co π Full story